TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
11,576
|
11,319
|
10,552 |
| Financial expenses |
10
|
12
|
42 |
| Earnings before taxes |
1,596
|
391
|
-271 |
| EBITDA |
1,465
|
413
|
-160 |
| Total assets |
9,628
|
8,612
|
8,942 |
| Current assets |
9,606
|
8,546
|
8,813 |
| Current liabilities |
2,291
|
2,639
|
2,798 |
| Equity capital |
7,206
|
5,930
|
6,120 |
| - share capital |
31
|
31
|
34 |
| Employees (average) |
27
|
27
|
31 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.8%
|
68.9%
|
68.4% |
| Turnover per employee |
429
|
419
|
340 |
| Profit as a percentage of turnover |
13.8%
|
3.5%
|
-2.6% |
| Return on assets (ROA) |
16.7%
|
4.7%
|
-2.6% |
| Current ratio |
419.3%
|
323.8%
|
315.0% |
| Return on equity (ROE) |
22.1%
|
6.6%
|
-4.4% |
| Change turnover |
224
|
1,621
|
793 |
| Change turnover % |
2%
|
17%
|
8% |
| Chg. No. of employees |
0
|
-4
|
2 |
| Chg. No. of employees % |
0%
|
-13%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.